Polo-like-kinase 1: A key cellular target for anti-HBV therapy?

Hepatology. 2017 Dec;66(6):1719-1721. doi: 10.1002/hep.29407. Epub 2017 Nov 6.

Authors

Michael M C Lai^{1

2

3}, Wen-Chi Su^{1

2}

Affiliations

¹ China Medical University, Taichung, Taiwan.
² Research Center for Emerging Viruses, China Medical University Hospital, Taichung, Taiwan.
³ Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.

PMID: 28749534
DOI: 10.1002/hep.29407

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cell Cycle Proteins*
Humans

Substances

Cell Cycle Proteins